The United States President's Emergency Plan For AIDS Relief (PEPFAR) is a United States governmental initiative to address the global HIV/AIDS epidemic and help save the lives of those suffering from the disease. Launched by U.S. President George W. Bush in 2003, as of May 2020, PEPFAR has provided about $90 billion in cumulative funding for HIV/AIDS treatment, prevention, and research since its inception, making it the largest global health program focused on a single disease in history until the COVID-19 pandemic. PEPFAR is implemented by a combination of U.S. government agencies in over 50 countries and overseen by the Global AIDS Coordinator at the United States Department of State. As of 2021, PEPFAR has saved over 20 million lives, primarily in Sub-Saharan Africa.
Sir Roy Malcolm Anderson is a leading international authority on the epidemiology and control of infectious diseases. He is the author, with Robert May, of the most highly cited book in this field, entitled Infectious Diseases of Humans: Dynamics and Control. His early work was on the population ecology of infectious agents before focusing on the epidemiology and control of human infections. His published research includes studies of the major viral, bacterial and parasitic infections of humans, wildlife and livestock. This has included major studies on HIV, SARS, foot and mouth disease, bovine tuberculosis, bovine spongiform encephalopathy, influenza A, antibiotic resistant bacteria, the neglected tropical diseases and most recently COVID-19. Anderson is the author of over 650 peer-reviewed scientific articles with an h citation index of 125.
Mario C. Raviglione has been professor at the University of Milan, Italy since March 2018. He directs the activities focused on global health and aiming at pursuing didactic and research in this field as part of the new Multidisciplinary Research in Health Science (MACH) Centre. Part of his activities are devoted to teaching global health principles to undergraduate medical students, making the University of Milan the first in Italy, and one of the pioneers world-wide, introducing global health as a module among the required courses. At the same university, Raviglione is now coordinating the establishment of the first international online Master Course in Global Health in Italy . In 2019 and 2020, he was also Professeur Titulaire at the Global Studies Institute (GSI), Université de Genève, Suisse. Through the GSI, he has worked within the context of the Institute of Global Health. Previously, between 2003 and 2017, he was director of the Global Tuberculosis Programme at the World Health Organization (WHO) . He graduated in medicine from the University of Turin in 1980 and then trained in internal medicine and Infectious Diseases at Cabrini Medical Center in New York City and at Beth Israel Medical Center in Boston where he was a Harvard University Clinical Fellow in Medicine and specialised in AIDS. Back in Europe, Raviglione joined WHO in 1991 as a Junior Professional Officer, and spent a few years working on TB and AIDS, TB epidemiology in Europe, and anti-TB drug resistance surveillance and response. In the mid-1990s, he set up both the WHO global drug resistance surveillance project and the WHO global TB surveillance and monitoring systems. Among his major achievements are the contributions to the development of the WHO's DOTS Strategy in 1995, and the direction of the development of both the Stop TB Strategy in 2006 and the End TB Strategy in 2014. During his years at WHO he worked with, and visited, more than 50 countries supporting their TB care, prevention, control and research activities. His research work has resulted in over 350 scientific articles and chapters on the topics of infectious diseases, HIV/AIDS, TB, and global health, including the TB chapters in the last eight editions of Harrison's Principles of Internal Medicine. He is editor of the 3rd and 4th edition of "Tuberculosis - A comprehensive international approach", a multi-author book, and associate editor of other books on public health, infectious diseases and tuberculosis. He directed the team that developed the book “Systematic screening for active tuberculosis – Principles and recommendations”, awarded by the British Medical Association as "Highly Commended Book" for Public Health in 2014. He is among the top 10 most cited authors in the TB field. His h-index is 107 and 87 (Scinapse) and his work has been cited over 55000 times. He is also among the top 25 Italian epidemiological scientists and the top 100 Italian scientists in general. As an expert in TB, he has worked as a teacher or visiting professor at Johns Hopkins University, University of Geneva, University of Modena and Reggio Emilia, and University of Pavia. He has been visiting professor at the University of Brescia and has recently lectured at major universities including Harvard, McGill and Sydney. He participates in a variety of board of directors, scientific and advisory committees, including those of the TB Alliance, Doctors with Africa CUAMM, BE Health Association, International Health Commission of the Missionary Sisters of the Sacred Heart - Cabrini Ministries ,Fondazione 3Bi. and the McGill Global Health Programs International Advisory Board. In 2017-2018 he was member of the Lancet Commission on TB. During 2015-2017 he conceived and co-organised, with WHO and the Russian Federation Ministry of Health, the first Global WHO Ministerial Conference on TB in the Sustainable Development Era, held in Moscow on 16-17 November 2017, and his team worked towards ensuring that TB is raised in the international political agenda through the United Nations General Assembly high-level meeting on TB that was held in 2018.
Joia Stapleton Mukherjee is an Associate Professor with the Division of Global Health Equity at the Brigham and Women's Hospital and the Department of Global Health and Social Medicine at Harvard Medical School. Since 2000, she has served as the Chief Medical Officer of Partners In Health, an international medical non-profit founded by Paul Farmer, Ophelia Dahl, and Jim Kim. She trained in Infectious Disease, Internal Medicine, and Pediatrics at the Massachusetts General Hospital and has an MPH from Harvard School of Public Health. Dr. Mukherjee has been involved in health care access and human rights issues since 1989, and she consults for the World Health Organization on the treatment of HIV and MDR-TB in developing countries. Her scholarly work focuses on the human rights aspect of HIV treatment and on the implementation of complex health interventions in resource-poor settings.
Awa Marie Coll-Seck is as Senegalese infectious diseases specialist and politician who served as Minister of Health of Senegal from 2001 to 2003 and again from 2012 to 2017. She also served as former Executive Director of the Roll Back Malaria Partnership and is on the board of directors of several notable global health organizations. She is an agenda contributor of the World Economic Forum.
The Joseph L. Mailman School of Public Health is the public health graduate school of Columbia University. Located on the Columbia University Medical Center campus in the Washington Heights neighborhood of Manhattan, New York City, the school is recognized by the Council on Education for Public Health.
Seth Franklin Berkley is an American medical epidemiologist, the CEO of Gavi, the Vaccine Alliance and a global advocate of the power of vaccines. He is the founder and former president and CEO of the International AIDS Vaccine Initiative (IAVI).
ICAP at Columbia University's Mailman School of Public Health supports programs and research that address HIV/AIDS and related conditions and works to strengthen health systems. ICAP currently supports HIV/AIDS prevention, care and treatment programs in 19 African countries including: Angola, Cameroon, Côte d'Ivoire, Democratic Republic of Congo, Ethiopia, Kenya, Lesotho, Malawi, Mali, Mozambique, Namibia, Sierra Leone, South Africa, South Sudan, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe. It also works in Central Asia, Ukraine, Georgia, Myanmar, Brazil, Guatemala, China, Jordan, Lebanon, and Turkey. ICAP supports several hundred project sites, which provide HIV prevention, care and treatment to hundreds of thousands of individuals.
Anita Rachlis, M.D. is a Canadian HIV/AIDS researcher and is the principal author of the HIV treatment guidelines in Canada. She is an associate scientist at the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, in Toronto, Ontario, Canada.
Agnes Binagwaho is a Rwandan pediatrician and co-founder and the former vice chancellor of the University of Global Health Equity (2017-2022). In 1996, she returned to Rwanda where she provided clinical care in the public sector as well as held many positions including the position of Permanent Secretary for the Ministry of Health of Rwanda from October 2008 until May 2011 and Minister of Health from May 2011 until July 2016. She has been a Professor of Global Health Delivery Practice since 2016 and a Professor of Pediatrics since 2017 at the University of Global Health Equity. She resides in Kigali.
mChip is a portable blood test device which is capable of diagnosing an infection of HIV or Syphilis within 15 minutes and could be used effectively against HIV/AIDS in developing countries. The mChip costs about US$ 1 and the entire diagnostic kit costs about US$ 100. mChip was developed so that people in regions with poor health facilities can access portable diagnosis for HIV/AIDS rather than travelling long distances to go to clinics for diagnosis.
Safiatou Thiam is a Senegalese public health doctor, a specialist in HIV/AIDS and former Minister of Health and Disease Prevention in the government of Cheikh Hadjibou Soumaré.She later became Executive Secretary of CNLS National Council against AIDS
Mary Jane Rotheram-Borus is a licensed clinical psychologist and professor with the University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences. Rotheram is the professor-in-residence in the Semel Institute for Neuroscience and Human Behavior. She is the Director of the Global Center for Children and Families at UCLA and the former director of the Center for HIV Identification, Prevention, and Treatment Services.
Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.
Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc) is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives
Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.
Roy D. Mugerwa was a Ugandan physician, cardiologist and researcher. His contribution to the world of academics include being a Professor Emeritus at Makerere University College of Health Sciences in Kampala, cardiology in Uganda, researching HIV/AIDS and tuberculosis, and his efforts to find an effective HIV vaccine.
Adaora Alise Adimora is an American doctor and academic. She is the Sarah Graham Kenan Distinguished Professor of Medicine and professor of epidemiology at the University of North Carolina School of Medicine. Her research centers on the transmission of HIV, as well as other sexually transmitted infections (STIs), among minority populations. Her work has highlighted the importance of social determinants of HIV transmission and the need for structural interventions to reduce risk. In 2019, she became an elected member of the National Academy of Medicine in recognition of her contributions.
Kimberly Y. Smith is an American scientific executive and medical doctor serving as the head of research and development at ViiV Healthcare.
Susan Swindells is an American AIDS researcher.
